发明名称 |
Combination therapy of a type II anti-CD20 antibody with a proteasome inhibitor |
摘要 |
<p>The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a proteasome inhibitor for the treatment of a patient suffering from cancer, particularly a CD20-expressing cancer. An aspect of the invention is a composition comprising a type II anti-CD20 antibody and a proteasome inhibitor. Another aspect of the invention is a kit comprising a type II anti-CD20 antibody and a proteasome inhibitor. Yet another aspect of the invention is a method for the treatment of a patient suffering from cancer comprising co-administering, to a patient in need of such treatment, a type II anti-CD20 antibody and a proteasome inhibitor.</p> |
申请公布号 |
AU2008315926(A1) |
申请公布日期 |
2009.04.30 |
申请号 |
AU20080315926 |
申请日期 |
2008.10.22 |
申请人 |
F. HOFFMANN-LA ROCHE AG;ROCHE GLYCART AG |
发明人 |
GEORG FERTIG;CHRISTIAN KLEIN;THOMAS FRIESS;PABLO UMANA |
分类号 |
A61K31/00;A61K39/395;A61P35/00 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|